Sign in
4

Changes in Ownership

MAIA Biotechnology, Inc. Filed Acc 0001127602-23-017884

Options or other derivatives

  • Chief Executive Officer acquired 123,760 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Vitoc Vlad · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-05-31 Grant or award : show line 1 in the form Stock Options +123,760 123,760 D
Loading xslF345X04/form4.xml…